New York, Feb 10, 2026, 07:42 EST — Premarket
- KVUE hovered near its previous session close in premarket indications, showing little movement ahead of the open
- Kenvue’s results are due out Feb. 17, but investors won’t get a conference call this time.
- Watch for the Feb. 11 dividend record date and the next moves toward closing the merger—both are shaping up as key milestones in the near term.
Kenvue Inc (KVUE.N) was flat in premarket action Tuesday, sticking close to $18.18 after closing out Monday at that exact price, a 0.28% gain.
That next big event is coming up fast. Kenvue plans to release its fourth-quarter and full-year 2025 numbers after the bell on Feb. 17. No quarterly conference call this time—management says that’s because of the ongoing deal with Kimberly-Clark.
Eyes on the dividend: Kenvue’s paying out $0.2075 per share to investors of record as of Feb. 11, with the cash headed their way on Feb. 25.
On Jan. 29, both the company and Kimberly-Clark announced that shareholders had signed off on the acquisition, clearing a major hurdle for a deal the two firms still expect to wrap up in the second half of 2026—pending regulatory sign-off and additional conditions. “An exciting milestone,” Kimberly-Clark CEO Mike Hsu said. Kenvue’s CEO, Kirk Perry, sounded upbeat as well, saying the companies “remain confident” in the combined group’s growth outlook. Kenvue
Kenvue investors are set to get $3.50 in cash plus 0.15 shares of Kimberly-Clark for every Kenvue share, according to Reuters calculations based on the November deal.
The stock’s performance now mirrors a deal spread as much as a consumer-health play. Kimberly-Clark’s moves—and any changes in timing forecasts—still have the power to drag KVUE in either direction.
Still, risks remain. Institutional Shareholder Services highlighted ongoing litigation issues and the market’s cool reception to the merger, calling them key factors for investors to consider.
KVUE bounced between $17.99 and $18.19 on Monday, with roughly 91 million shares changing hands, data from Investing.com showed.
No earnings call this time, so management’s Feb. 17 release will carry extra significance—especially any details they omit. Investors are set to comb through SEC paperwork like Form 8-K for clues on potential deal news or other key developments.
